pARU :: ARU - GFP was cloned by amplification of a part of ARU coupled to GFP - tNOS from pFER :: ARU - GFP with primers 5 ′- GCGTTAACGCTTTACCTCA - 3 ′ ( including the natural HpaI site in ARU) and 5 ′- TTTGGATCCAGTAACATAGATGACACCGCG - 3 ′ ( introducing a BamHI site after tNOS ).	"ARU	1	4	Gene/Protein"	"GFP	14	17	Gene/Protein"	"ARU	59	62	Gene/Protein"	"GFP	74	77	Gene/Protein"	"ARU	98	101	Gene/Protein"	"GFP	104	107	Gene/Protein"	"HpaI	176	180	Gene/Protein"	"ARU	189	192	Gene/Protein"	"BamHI	256	261	Gene/Protein"	"[{""token"": ""ARU"", ""start_span"": 1, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""HpaI"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""BamHI"", ""start_span"": 256, ""end_span"": 261, ""type"": ""Gene/Protein""}]"
Cells then were rinsed and incubated for 10 min at RT in PBS containing 0. 5% BSA ( for blocking ), and stained with either mouse anti - human phospho - p44 / 42 MAPK alexa fluor 488 ( Cell Signaling Technology) or isotype control mouse IgG1 alexa fluor 488 ( BioLegend ).	"BSA	78	81	Gene/Protein"	"mouse	124	129	Organism/Species"	"human	137	142	Organism/Species"	"p44	153	156	Gene/Protein"	"MAPK	162	166	Gene/Protein"	"alexa fluor	167	178	Chemical/Drug"	"mouse	231	236	Organism/Species"	"IgG1	237	241	Gene/Protein"	"alexa fluor	242	253	Chemical/Drug"	"[{""token"": ""BSA"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""p44"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""alexa fluor"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""mouse"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""IgG1"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""alexa fluor"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Chemical/Drug""}]"
S100A8 and A9 have been shown to exert their effects via CD36 and CD11b / CD18 ( Mac - 1) [ 30 − 32 ]. CD11b / CD18 is well expressed in freshly isolated neutrophils, but CD36 is not ( Fig. 5A, upper panel ).	"S100A8	0	6	Gene/Protein"	"A9	11	13	Gene/Protein"	"CD36	57	61	Gene/Protein"	"CD11b	66	71	Gene/Protein"	"CD18	74	78	Gene/Protein"	"Mac - 1	81	88	Gene/Protein"	"CD11b	103	108	Gene/Protein"	"CD18	111	115	Gene/Protein"	"CD36	171	175	Gene/Protein"	"[{""token"": ""S100A8"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""A9"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""CD36"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Mac - 1"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CD36"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}]"
The JMJD2 family consists of 6 subtypes ( JMJD2A - JMJD2F ); JMJD2B acts as a transcriptional activator of targeted genes through demethylation of specific lysine residues on H3K9me3. 10, 11 JMJD2B is located in the nucleus in dividing cells and has demethylase activity to H3K9me3. 12 Previous research has mainly focused on the oncogenic potential of JMJD2B.	"JMJD2	4	9	Gene/Protein"	"JMJD2A	42	48	Gene/Protein"	"JMJD2F	51	57	Gene/Protein"	"JMJD2B	61	67	Gene/Protein"	"transcriptional activator	78	103	Gene/Protein"	"lysine	156	162	Chemical/Drug"	"JMJD2B	191	197	Gene/Protein"	"demethylase	250	261	Gene/Protein"	"JMJD2B	353	359	Gene/Protein"	"[{""token"": ""JMJD2"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2A"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2F"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 78, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""lysine"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""JMJD2B"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""demethylase"", ""start_span"": 250, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 353, ""end_span"": 359, ""type"": ""Gene/Protein""}]"
Also, we detected increased protein CXCL12 serum levels in both individuals with RRMS ( n = 24) and SPMS ( n = 28) compared to controls ( n = 21, ANOVA, RRMS and SPMS each P < 0. 05) ( Fig. 3B, Tables S6 and S7 ). Fig. 3. Cxcr4 expression in white blood cells and CXCL12 protein in serum of individuals with MS. ( A) Cxcr4 mRNA was quantified by real - time PCR from white blood cells of individuals with relapsing - remitting MS ( RR - MS; gray bars, n = 32 ), secondary chronic - progressive MS ( SP - MS; black bars, n = 22) and controls ( white bars, n = 25 ).	"CXCL12	36	42	Gene/Protein"	"Cxcr4	222	227	Gene/Protein"	"CXCL12	264	270	Gene/Protein"	"MS	308	310	Disease/Disorder"	"Cxcr4	317	322	Gene/Protein"	"relapsing - remitting MS	405	429	Disease/Disorder"	"RR - MS	432	439	Disease/Disorder"	"secondary chronic - progressive MS	462	496	Disease/Disorder"	"SP - MS	499	506	Disease/Disorder"	"[{""token"": ""CXCL12"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 222, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""CXCL12"", ""start_span"": 264, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""MS"", ""start_span"": 308, ""end_span"": 310, ""type"": ""Disease/Disorder""}, {""token"": ""Cxcr4"", ""start_span"": 317, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""relapsing - remitting MS"", ""start_span"": 405, ""end_span"": 429, ""type"": ""Disease/Disorder""}, {""token"": ""RR - MS"", ""start_span"": 432, ""end_span"": 439, ""type"": ""Disease/Disorder""}, {""token"": ""secondary chronic - progressive MS"", ""start_span"": 462, ""end_span"": 496, ""type"": ""Disease/Disorder""}, {""token"": ""SP - MS"", ""start_span"": 499, ""end_span"": 506, ""type"": ""Disease/Disorder""}]"
Puf proteins are evolutionary conserved in eukaryotes and are characterized by the presence of a RNA - binding Puf domain, named after the Drosophila melanogaster protein Pumilio and the Caenorhabditis elegans protein fem - 3 binding factor ( FBF ), and consisting of eight imperfect repeats of 36 amino acids ( PFAM: PF00806) [ 16 ], [ 17 ].	"Puf	0	3	Gene/Protein"	"eukaryotes	43	53	Organism/Species"	"Puf	111	114	Gene/Protein"	"Drosophila melanogaster	139	162	Organism/Species"	"Pumilio	171	178	Gene/Protein"	"Caenorhabditis elegans	187	209	Organism/Species"	"fem - 3 binding factor	218	240	Gene/Protein"	"FBF	243	246	Gene/Protein"	"amino acids	298	309	Chemical/Drug"	"[{""token"": ""Puf"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""eukaryotes"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""Puf"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila melanogaster"", ""start_span"": 139, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""Pumilio"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Caenorhabditis elegans"", ""start_span"": 187, ""end_span"": 209, ""type"": ""Organism/Species""}, {""token"": ""fem - 3 binding factor"", ""start_span"": 218, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""FBF"", ""start_span"": 243, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 298, ""end_span"": 309, ""type"": ""Chemical/Drug""}]"
The identified tyrosine phosphorylation sites in full - length ALK overlap with the predicted ones ( PhosphoMotif, Human Protein Reference Database, http :// www. hprd. org / PhosphoMotif_finder ), and cover, with only one exception, the entire set of mapped phosphotyrosine sites from earlier investigations of EML4 – ALK and nucleophosmin ( NPM )– ALK 29, 30.	"tyrosine	15	23	Chemical/Drug"	"ALK	63	66	Gene/Protein"	"Human	115	120	Organism/Species"	"phosphotyrosine	259	274	Chemical/Drug"	"EML4	312	316	Gene/Protein"	"ALK	319	322	Gene/Protein"	"nucleophosmin	327	340	Gene/Protein"	"NPM	343	346	Gene/Protein"	"ALK	350	353	Gene/Protein"	"[{""token"": ""tyrosine"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""ALK"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Human"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""phosphotyrosine"", ""start_span"": 259, ""end_span"": 274, ""type"": ""Chemical/Drug""}, {""token"": ""EML4"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 319, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""nucleophosmin"", ""start_span"": 327, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""NPM"", ""start_span"": 343, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 350, ""end_span"": 353, ""type"": ""Gene/Protein""}]"
Furthermore, identified downstream targets of ALK detected in this phosphoprofiling, such as mitogen - activated protein kinase ( MAPK) 1, MAPK3 [ extracellular signal - related kinase ( ERK) 2 / 1 ], glycogen synthase kinase - 3α, STAT3, FAK, and CRKL ( Table S1 ), showed decreased phosphorylation upon abrogation of ALK activity in several neuroblastoma cell lines ( Fig. S1 ).	"ALK	46	49	Gene/Protein"	"mitogen - activated protein kinase	93	127	Gene/Protein"	"MAPK3	139	144	Gene/Protein"	"glycogen synthase kinase - 3α	201	230	Gene/Protein"	"STAT3	232	237	Gene/Protein"	"FAK	239	242	Gene/Protein"	"CRKL	248	252	Gene/Protein"	"ALK	319	322	Gene/Protein"	"neuroblastoma	343	356	Disease/Disorder"	"[{""token"": ""ALK"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 93, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""MAPK3"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""glycogen synthase kinase - 3\u03b1"", ""start_span"": 201, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""FAK"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""CRKL"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 319, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 343, ""end_span"": 356, ""type"": ""Disease/Disorder""}]"
The antibodies used were anti - STAT3 (# 9132 ), anti - p - STAT3 ( Tyr705) (# 9145 ), anti - p - ALK ( Tyr1278) (# 6941 ), anti - p - ERK ( phospho - p44 / 42) (# 9101 ), anti - N - MYC (# 9405) ( all Cell Signaling Technology, MA, USA ), anti - FLAG ( clone M2, # F3165; Sigma, Stockholm, Sweden ), anti - ERK ( 610123; BD Transduction, Stockholm, Sweden ), and anti - ALK ( mAb135 and mAb31) 10.	"STAT3	32	37	Gene/Protein"	"STAT3	60	65	Gene/Protein"	"ALK	98	101	Gene/Protein"	"ERK	135	138	Gene/Protein"	"p44	151	154	Gene/Protein"	"N - MYC	179	186	Gene/Protein"	"FLAG	247	251	Gene/Protein"	"ERK	308	311	Gene/Protein"	"ALK	371	374	Gene/Protein"	"[{""token"": ""STAT3"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""p44"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""N - MYC"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""FLAG"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 308, ""end_span"": 311, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 371, ""end_span"": 374, ""type"": ""Gene/Protein""}]"
Assay was performed immediately ( a and d) and 30 mins ( b) after nicotine stimulus of in - vitro culture. a Change of fluorescence intensity of Ca2 + after the stimulus of nicotine at different concentrations. b Change of fluorescence intensity of calcineurin phosphatase activity of CaN calcineurin after the stimulus of nicotine at different concentrations. c Expression of the subtypes of nAChR in BMSCs. d Effects of MLA on nicotine ’ s augmentation of intracellular Ca2 + concentration in BMSCs.	"nicotine	66	74	Chemical/Drug"	"nicotine	173	181	Chemical/Drug"	"calcineurin	249	260	Gene/Protein"	"phosphatase	261	272	Gene/Protein"	"CaN	285	288	Gene/Protein"	"calcineurin	289	300	Gene/Protein"	"nicotine	323	331	Chemical/Drug"	"nAChR	393	398	Gene/Protein"	"nicotine	429	437	Chemical/Drug"	"[{""token"": ""nicotine"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""calcineurin"", ""start_span"": 249, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""CaN"", ""start_span"": 285, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 289, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 323, ""end_span"": 331, ""type"": ""Chemical/Drug""}, {""token"": ""nAChR"", ""start_span"": 393, ""end_span"": 398, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 429, ""end_span"": 437, ""type"": ""Chemical/Drug""}]"
These results implied that NFATc2 could bind to the Sox9 promoter and recruit HDAC1, which also binds to the Sox9 promoter to form the complex, and the latter could reduce H3K9ac and H3K14ac levels in the Sox9 promoter and decrease the expression of Sox9. Fig. 6Effects of nicotine on interaction of NFATc2 and HDAC1 in BMSCs.	"NFATc2	27	33	Gene/Protein"	"Sox9	52	56	Gene/Protein"	"HDAC1	78	83	Gene/Protein"	"Sox9	109	113	Gene/Protein"	"Sox9	205	209	Gene/Protein"	"Sox9	250	254	Gene/Protein"	"nicotine	273	281	Chemical/Drug"	"NFATc2	300	306	Gene/Protein"	"HDAC1	311	316	Gene/Protein"	"[{""token"": ""NFATc2"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 273, ""end_span"": 281, ""type"": ""Chemical/Drug""}, {""token"": ""NFATc2"", ""start_span"": 300, ""end_span"": 306, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 311, ""end_span"": 316, ""type"": ""Gene/Protein""}]"
( C) The expression levels of 4CL ( 4 - coumarate: CoAligase ), CCoAOMT ( caffeoyl CoA O - methyltransferase ), and C3H ( cinnamic acid 3 - hydroxylase) were detected in P7 - 1 transgenic ( P7 - 1 - OE) and wild type ( WT) Arabidopsis flowers using quantitative real - time polymerase chain reaction ( qRT - PCR) with the EF1a gene as an internal standard.	"4CL	30	33	Gene/Protein"	"CCoAOMT	64	71	Gene/Protein"	"caffeoyl CoA O - methyltransferase	74	108	Gene/Protein"	"C3H	116	119	Gene/Protein"	"cinnamic acid 3 - hydroxylase	122	151	Gene/Protein"	"P7 - 1	170	176	Gene/Protein"	"P7 - 1	190	196	Gene/Protein"	"Arabidopsis	223	234	Organism/Species"	"EF1a	322	326	Gene/Protein"	"[{""token"": ""4CL"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CCoAOMT"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""caffeoyl CoA O - methyltransferase"", ""start_span"": 74, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""C3H"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""cinnamic acid 3 - hydroxylase"", ""start_span"": 122, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""EF1a"", ""start_span"": 322, ""end_span"": 326, ""type"": ""Gene/Protein""}]"
Results of Comprehensive Investigation of Hub Meta - States and Schizophrenia ( A) Histograms of within - subject mean meta - state recurrence rate ( average number of re - visitations made to the meta - states realized) and SZ regression effect on this quantity ( SZ effect = 0. 86, p - value = 0. 0001 ); ( B) SZ effect on number of distinct meta - states with indicated within - subject recurrence rate ( inset zooms on rates 3 – 18) along with SZ effect on the largest number of visits to the same state ( SZ effect = 1. 42, p - value = 4. 96e - 005 ( also see ( C) for distribution )); ( C) Number of subjects whose most visited meta - state had indicated recurrence rate; ( D) Mean longest uninterrupted period of hub state occupancy ( recall that level k hubs are occupied k times, not necessarily in uninterrupted stretches) and SZ regression effect ( SZ effect = 1. 18, p - value = 4. 60e - 005 ); ( E) Effect of SZ on hub saturation, evaluated separately for hubs of each level k, k = 4, 5 ,…, 36.	"Schizophrenia	64	77	Disease/Disorder"	"SZ	225	227	Disease/Disorder"	"SZ	265	267	Disease/Disorder"	"SZ	312	314	Disease/Disorder"	"SZ	448	450	Disease/Disorder"	"SZ	510	512	Disease/Disorder"	"SZ	837	839	Disease/Disorder"	"SZ	860	862	Disease/Disorder"	"SZ	922	924	Disease/Disorder"	"[{""token"": ""Schizophrenia"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 225, ""end_span"": 227, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 265, ""end_span"": 267, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 312, ""end_span"": 314, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 448, ""end_span"": 450, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 510, ""end_span"": 512, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 837, ""end_span"": 839, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 860, ""end_span"": 862, ""type"": ""Disease/Disorder""}, {""token"": ""SZ"", ""start_span"": 922, ""end_span"": 924, ""type"": ""Disease/Disorder""}]"
The expressions of 7 ICs on CD4 + T cells ( PD - 1, CTLA - 4, LAG - 3, TIGIT, TIM - 3, CD160 and 2B4) were measured by multiparametric flow cytometry ( S1 Fig ).	"ICs	21	24	Gene/Protein"	"CD4	28	31	Gene/Protein"	"PD - 1	44	50	Gene/Protein"	"CTLA - 4	52	60	Gene/Protein"	"LAG - 3	62	69	Gene/Protein"	"TIGIT	71	76	Gene/Protein"	"TIM - 3	78	85	Gene/Protein"	"CD160	87	92	Gene/Protein"	"2B4	97	100	Gene/Protein"	"[{""token"": ""ICs"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD160"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""2B4"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}]"
The frequencies of CD4 + T cells expressing these ICs were variable ( median ( IQR) of 16. 7% ( 13. 2 – 22. 7 ), 12. 2% ( 8. 8 – 16. 4 ), 12. 0% ( 8. 9 – 16. 1 ), 9. 5% ( 3. 5 – 18. 5 ), 1. 1% ( 0. 8 – 2. 5 ), 0. 8% ( 0. 6 – 1. 5) and 0. 7% ( 0. 6 – 1. 0) for TIGIT, PD - 1, LAG - 3, 2B4, CD160, TIM - 3 and CTLA - 4 respectively) ( Fig 1A ).	"CD4	19	22	Gene/Protein"	"ICs	50	53	Gene/Protein"	"TIGIT	260	265	Gene/Protein"	"PD - 1	267	273	Gene/Protein"	"LAG - 3	275	282	Gene/Protein"	"2B4	284	287	Gene/Protein"	"CD160	289	294	Gene/Protein"	"TIM - 3	296	303	Gene/Protein"	"CTLA - 4	308	316	Gene/Protein"	"[{""token"": ""CD4"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""ICs"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 267, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 275, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""2B4"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""CD160"", ""start_span"": 289, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 296, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 308, ""end_span"": 316, ""type"": ""Gene/Protein""}]"
The two polypeptides share the greatest degree of similarity with the characterized Pi transporters from mouse - ear cress ( Arabidopsis thaliana) [ 14 ], [ 25 ], tomato ( Lycopersicon esculentum L .) [ 15 ], potato ( Solanum tuberosum L .) [ 26] and barrel clover ( Medicago truncatula) [ 27 ].	"Pi transporters	84	99	Gene/Protein"	"mouse - ear cress	105	122	Organism/Species"	"Arabidopsis thaliana	125	145	Organism/Species"	"tomato	163	169	Organism/Species"	"Lycopersicon esculentum L	172	197	Organism/Species"	"potato	209	215	Organism/Species"	"Solanum tuberosum L	218	237	Organism/Species"	"barrel clover	251	264	Organism/Species"	"Medicago truncatula	267	286	Organism/Species"	"[{""token"": ""Pi transporters"", ""start_span"": 84, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""mouse - ear cress"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis thaliana"", ""start_span"": 125, ""end_span"": 145, ""type"": ""Organism/Species""}, {""token"": ""tomato"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""Lycopersicon esculentum L"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""potato"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Solanum tuberosum L"", ""start_span"": 218, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""barrel clover"", ""start_span"": 251, ""end_span"": 264, ""type"": ""Organism/Species""}, {""token"": ""Medicago truncatula"", ""start_span"": 267, ""end_span"": 286, ""type"": ""Organism/Species""}]"
The two Pi transporters from soybean have a very high degree of identity with fungal Pi transporters from the mycorrhizal fungus Glomus versiforme ( GvPT) and the budding yeast Saccharomyces cerevisiae ( PHO84 ).	"Pi transporters	8	23	Gene/Protein"	"soybean	29	36	Organism/Species"	"Pi transporters	85	100	Gene/Protein"	"fungus	122	128	Organism/Species"	"Glomus versiforme	129	146	Organism/Species"	"GvPT	149	153	Gene/Protein"	"yeast	171	176	Organism/Species"	"Saccharomyces cerevisiae	177	201	Organism/Species"	"PHO84	204	209	Gene/Protein"	"[{""token"": ""Pi transporters"", ""start_span"": 8, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""soybean"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""Pi transporters"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""fungus"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""Glomus versiforme"", ""start_span"": 129, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""GvPT"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""yeast"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Organism/Species""}, {""token"": ""Saccharomyces cerevisiae"", ""start_span"": 177, ""end_span"": 201, ""type"": ""Organism/Species""}, {""token"": ""PHO84"", ""start_span"": 204, ""end_span"": 209, ""type"": ""Gene/Protein""}]"
The open reading frames of GmPT1 and GmPT2 were separately subcloned into yeast expression vector p112A1NE [ 56] to create GmPT1 / p112A1NE and GmPT2 / p112A1NE, where expression of GmPT1 or GmPT2 gene was driven by the alcohol dehydrogenase promoter 1 ( ADH1 ).	"GmPT1	27	32	Gene/Protein"	"GmPT2	37	42	Gene/Protein"	"yeast	74	79	Organism/Species"	"GmPT1	123	128	Gene/Protein"	"GmPT2	144	149	Gene/Protein"	"GmPT1	182	187	Gene/Protein"	"GmPT2	191	196	Gene/Protein"	"alcohol dehydrogenase	220	241	Gene/Protein"	"ADH1	255	259	Gene/Protein"	"[{""token"": ""GmPT1"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""yeast"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""GmPT1"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""alcohol dehydrogenase"", ""start_span"": 220, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""ADH1"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}]"
These constructs were transformed into the yeast mutant MB192 ( MATa pho3 - 1 Δpho84 :: HIS3 ade2 leu2 - 3, 112 his3 - 532 trp1 - 289 ura3 - 1, 2 can1) [ 28] as described [ 57 ].	"yeast	43	48	Organism/Species"	"pho3	69	73	Gene/Protein"	"HIS3	88	92	Gene/Protein"	"ade2	93	97	Gene/Protein"	"leu2	98	102	Gene/Protein"	"his3	112	116	Gene/Protein"	"trp1	123	127	Gene/Protein"	"ura3	134	138	Gene/Protein"	"can1	146	150	Gene/Protein"	"[{""token"": ""yeast"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""pho3"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""HIS3"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""ade2"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""leu2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""his3"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""trp1"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""ura3"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""can1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}]"
The addition of NGF / NT3 or BDNF into COL, LM and FN substrates enhanced maximum neurite length compared with COL substrate except COL + BDNF cultures.	"NGF	16	19	Gene/Protein"	"NT3	22	25	Gene/Protein"	"BDNF	29	33	Gene/Protein"	"COL	39	42	Gene/Protein"	"LM	44	46	Gene/Protein"	"FN	51	53	Gene/Protein"	"COL	111	114	Gene/Protein"	"COL	132	135	Gene/Protein"	"BDNF	138	142	Gene/Protein"	"[{""token"": ""NGF"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 44, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}]"
Collagen gels were also combined with NGF / NT3 ( COL + NGF / NT3) or BDNF ( COL + BDNF ).	"Collagen	0	8	Gene/Protein"	"NGF	38	41	Gene/Protein"	"NT3	44	47	Gene/Protein"	"COL	50	53	Gene/Protein"	"NGF	56	59	Gene/Protein"	"NT3	62	65	Gene/Protein"	"BDNF	70	74	Gene/Protein"	"COL	77	80	Gene/Protein"	"BDNF	83	87	Gene/Protein"	"[{""token"": ""Collagen"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}]"
The amplified fragments were introduced into BamHI – EcoRI sites of the pY13 - TEF1 expression vector, resulting in the pY13 - TEF1 - 470, pY13 - TEF1 - 488, pY13 - TEF1 - 406, pY13 - TEF1 - 607, pY13 - TEF1 - 108, and pY13 - TEF1 - 901 plasmids, respectively.	"BamHI	45	50	Gene/Protein"	"EcoRI	53	58	Gene/Protein"	"TEF1	79	83	Gene/Protein"	"TEF1	127	131	Gene/Protein"	"TEF1	146	150	Gene/Protein"	"TEF1	165	169	Gene/Protein"	"TEF1	184	188	Gene/Protein"	"TEF1	203	207	Gene/Protein"	"TEF1	226	230	Gene/Protein"	"[{""token"": ""BamHI"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""EcoRI"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 226, ""end_span"": 230, ""type"": ""Gene/Protein""}]"
The results showed that 28 orthologs of the JEN family from Aspergillus oryzae, Aspergillus fumigatus, Aspergillus nidulans, Y. lipolytica, Kluyveromyces lactis, Candida albicans, Kluyveromyces thermotolerans, S. cerevisiae, Debaryomyces hansenii and Neurospora crassa had highly conserved sequences.	"JEN	44	47	Gene/Protein"	"Aspergillus oryzae	60	78	Organism/Species"	"Aspergillus fumigatus	80	101	Organism/Species"	"Aspergillus nidulans	103	123	Organism/Species"	"Kluyveromyces lactis	140	160	Organism/Species"	"Candida albicans	162	178	Organism/Species"	"Kluyveromyces thermotolerans	180	208	Organism/Species"	"Debaryomyces hansenii	225	246	Organism/Species"	"Neurospora crassa	251	268	Organism/Species"	"[{""token"": ""JEN"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Aspergillus oryzae"", ""start_span"": 60, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Aspergillus fumigatus"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""Aspergillus nidulans"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""Kluyveromyces lactis"", ""start_span"": 140, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""Candida albicans"", ""start_span"": 162, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""Kluyveromyces thermotolerans"", ""start_span"": 180, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""Debaryomyces hansenii"", ""start_span"": 225, ""end_span"": 246, ""type"": ""Organism/Species""}, {""token"": ""Neurospora crassa"", ""start_span"": 251, ""end_span"": 268, ""type"": ""Organism/Species""}]"
